Progressive myelopathy associated with spinal epidural lipomatosis in three non-obese patients with type 1 diabetes mellitus.
Mechanisms of diabetes mellitus-induced bone fragility.
Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL; IOF Bone and Diabetes Working Group.
Nat Rev Endocrinol. 2017 Apr;13(4):208-219. doi: 10.1038/nrendo.2016.153. Epub 2016 Sep 23.
Autoimmunity to tetraspanin-7 in type 1 diabetes.
McLaughlin KA, Tombs MA, Christie MR.
Med Microbiol Immunol. 2020 Aug;209(4):437-445. doi: 10.1007/s00430-020-00674-2. Epub 2020 Apr 20.
Single-cell RNA sequencing analysis reveals the relationship of bone marrow and osteopenia in STZ-induced type 1 diabetic mice.
Zhong J, Mao X, Li H, Shen G, Cao X, He N, Wang J, Xu L, Chen J, Song X, Liu S, Zhang X, Shen Y, Wang LL, Xiang C, Chen YY.
J Adv Res. 2022 Nov;41:145-158. doi: 10.1016/j.jare.2022.01.006. Epub 2022 Jan 21.
Progressive myelopathy associated with spinal epidural lipomatosis in three non-obese patients with type 1 diabetes mellitus.
Lotan I, Charlson RW, Fatterpekar GM, Shapiro M, Smith ML, William C, Kister I.
J Neurol Sci. 2020 Apr 15;411:116688. doi: 10.1016/j.jns.2020.116688. Epub 2020 Jan 16.
Multisite chronic pain and the risk of autoimmune diseases: A Mendelian randomization study.
Tang Y, Liu W, Kong W, Zhang S, Zhu T.
Front Immunol. 2023 Feb 9;14:1077088. doi: 10.3389/fimmu.2023.1077088. eCollection 2023.
Painful neuropathy: Mechanisms.
Lee-Kubli CA, Calcutt NA.
Handb Clin Neurol. 2014;126:533-57. doi: 10.1016/B978-0-444-53480-4.00034-5.
Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus.
Hilder R, Tsai K, Quandt Z, Isaacs D, Drakaki A, Xing Y, In GK, Angell TE, Lechner MG.
Front Endocrinol (Lausanne). 2023 Oct 31;14:1242830. doi: 10.3389/fendo.2023.1242830. eCollection 2023.
Diabetes in stiff-person syndrome.
Heneberg P.
Trends Endocrinol Metab. 2023 Oct;34(10):640-651. doi: 10.1016/j.tem.2023.07.005. Epub 2023 Aug 14.
A pathogenic role for IL-10 signalling in capillary stalling and cognitive impairment in type 1 diabetes.
Sharma S, Cheema M, Reeson PL, Narayana K, Boghozian R, Cota AP, Brosschot TP, FitzPatrick RD, Körbelin J, Reynolds LA, Brown CE.
Nat Metab. 2024 Nov;6(11):2082-2099. doi: 10.1038/s42255-024-01159-9. Epub 2024 Nov 4.
MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus.
Hough FS, Pierroz DD, Cooper C, Ferrari SL; IOF CSA Bone and Diabetes Working Group.
Eur J Endocrinol. 2016 Apr;174(4):R127-38. doi: 10.1530/EJE-15-0820. Epub 2015 Nov 4.
